Global Summit on Heart Diseases and Therapeutics
University of Verona, Italy
Title: The outcome of percutaneous atrial septal defect / patent foramen ovale closure, 15 years single center experience
Biography: Mebratu Alebachew Gebrie
King et al., first time described Percutaneous Trans-catheter Closure in 1976. After that, with time after Paediatric population, catheter interventions for atrial septal defect (ASD) have been adapted for adult population. The most useful clinical benefits of this procedure are the significant improvement of symptoms and routine life activities without major cardiac surgery.This study aimed to assess a single institutional experience of the ASD closure and Patent Foramen Ovale Repair early and late outcome after Percutaneous Transcatheter Closure.A retrospective observational cohort study designed for percutaneous PFO/ASD closure patients at a single centre. We enrolled study group from February 2000 to June 2015. We collected data from patient`s electronic folders. In entire population, N=126 (80%) and N=25 (20%) of the patients underwent PFO and ASD closure, respectively.